These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 30879543)

  • 21. Potential role of antibodies against cardiac Kv channel-interacting protein 2 in dilated cardiomyopathy.
    Landsberger M; Staudt A; Choudhury S; Trimpert C; Herda LR; Klingel K; Kandolf R; Schultheiss HP; Kroemer HK; Völker U; Felix SB
    Am Heart J; 2008 Jul; 156(1):92-99.e2. PubMed ID: 18585502
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Influence of heart failure on nucleolar organization and protein expression in human hearts.
    Roselló-Lletí E; Rivera M; Cortés R; Azorín I; Sirera R; Martínez-Dolz L; Hove L; Cinca J; Lago F; González-Juanatey JR; Salvador A; Portolés M
    Biochem Biophys Res Commun; 2012 Feb; 418(2):222-8. PubMed ID: 22244875
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The influence of diastolic and systolic function on exercise performance in heart failure due to dilated cardiomyopathy or ischemic heart disease.
    Pepi M; Agostoni P; Marenzi G; Dorai E; Guazzi M; Lauri G; Maltagliati A; Guazzi M
    Eur J Heart Fail; 1999 Jun; 1(2):161-7. PubMed ID: 10937926
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cardiac protein changes in ischaemic and dilated cardiomyopathy: a proteomic study of human left ventricular tissue.
    Roselló-Lletí E; Alonso J; Cortés R; Almenar L; Martínez-Dolz L; Sánchez-Lázaro I; Lago F; Azorín I; Juanatey JR; Portolés M; Rivera M
    J Cell Mol Med; 2012 Oct; 16(10):2471-86. PubMed ID: 22435364
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Electroanatomic Properties of the Myocardium Predict Response to CD34+ Cell Therapy in Patients With Ischemic and Nonischemic Heart Failure.
    Zemljic G; Poglajen G; Sever M; Cukjati M; Frljak S; Androcec V; Cernelc P; Haddad F; Vrtovec B
    J Card Fail; 2017 Feb; 23(2):153-160. PubMed ID: 27523610
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lower levels of the host protective IL-10 in DCM--a feature of autoimmune pathogenesis?
    Lindberg E; Magnusson Y; Karason K; Andersson B
    Autoimmunity; 2008 Sep; 41(6):478-83. PubMed ID: 18781475
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Improvement of peripheral endothelial dysfunction by acute vitamin C application: different effects in patients with coronary artery disease, ischemic, and dilated cardiomyopathy.
    Erbs S; Gielen S; Linke A; Möbius-Winkler S; Adams V; Baither Y; Schuler G; Hambrecht R
    Am Heart J; 2003 Aug; 146(2):280-5. PubMed ID: 12891196
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impact of cardiac transplantation on molecular pathology of ET-1, VEGF-C, and mitochondrial metabolism and morphology in dilated versus ischemic cardiomyopathic patients.
    Aharinejad S; Schäfer R; Hofbauer R; Abraham D; Blumer R; Miksovsky A; Traxler H; Pullirsch D; Alexandrowicz R; Taghavi S; Kocher A; Laufer G
    Transplantation; 2001 Sep; 72(6):1043-9. PubMed ID: 11579298
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Venoarterial Extracorporeal Membrane Oxygenation Support as a Bridge to Heart Transplant: Report of 3 Cases.
    Gedik E; Ulaş A; Ersoy Ö; Atar F; Camkıran Fırat A; Pirat A
    Exp Clin Transplant; 2016 Nov; 14(Suppl 3):121-124. PubMed ID: 27805530
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Decrease of circulating myeloid dendritic cells in patients with chronic heart failure.
    Pistulli R; Hammer N; Rohm I; Kretzschmar D; Jung C; Figulla HR; Yilmaz A
    Acta Cardiol; 2016 Apr; 71(2):165-72. PubMed ID: 27090038
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The spatial pattern of coronary capillaries in patients with dilated, ischemic, or inflammatory cardiomyopathy.
    Karch R; Neumann F; Ullrich R; Neumüller J; Podesser BK; Neumann M; Schreiner W
    Cardiovasc Pathol; 2005; 14(3):135-44. PubMed ID: 15914298
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Integrative Proteomic Analysis Reveals the Cytoskeleton Regulation and Mitophagy Difference Between Ischemic Cardiomyopathy and Dilated Cardiomyopathy.
    Liu M; Zhai L; Yang Z; Li S; Liu T; Chen A; Wang L; Li Y; Li R; Li C; Tan M; Chen Z; Qian J
    Mol Cell Proteomics; 2023 Dec; 22(12):100667. PubMed ID: 37852321
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Guidelines from the French Society of Cardiology for including non-emergency adult patients in a waiting list for cardiac transplantation].
    Arch Mal Coeur Vaiss; 1997 Oct; 90(10):1437-42. PubMed ID: 9539847
    [No Abstract]   [Full Text] [Related]  

  • 34. Is Myocarditis an Independent Risk Factor for Post-Transplant Mortality in Pediatric Heart Transplant Recipients?
    Garbern JC; Gauvreau K; Blume ED; Singh TP
    Circ Heart Fail; 2016 Jan; 9(1):e002328. PubMed ID: 26699389
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunohistochemical study of remodeling of myocardial lymphatic and blood microvascular structures in terminal heart failure: differences between ischemic and dilated cardiomyopathy.
    Dashkevich A; Bloch W; Antonyan A; Goebel H; Fries JU; Schlensak C; Beyersdorf F; Geissler HJ
    Lymphology; 2010 Sep; 43(3):110-7. PubMed ID: 21226413
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effect of the sequential therapy in end-stage heart failure (ESHF)--from ECMO, through the use of implantable pump for a pneumatic heart assist system, Religa Heart EXT, as a bridge for orthotopic heart transplant (OHT). Case study.
    Religa G; Jasińska M; Czyżewski Ł; Torba K; Różański J
    Ann Transplant; 2014 Oct; 19():537-40. PubMed ID: 25330851
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impact of Ischemic Heart Failure Etiology on Cardiac Recovery During Mechanical Unloading.
    Wever-Pinzon J; Selzman CH; Stoddard G; Wever-Pinzon O; Catino A; Kfoury AG; Diakos NA; Reid BB; McKellar S; Bonios M; Koliopoulou A; Budge D; Kelkhoff A; Stehlik J; Fang JC; Drakos SG
    J Am Coll Cardiol; 2016 Oct; 68(16):1741-1752. PubMed ID: 27737740
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Desmin-free cardiomyocytes and myocardial dysfunction in end stage heart failure.
    Di Somma S; Di Benedetto MP; Salvatore G; Agozzino L; Ferranti F; Esposito S; La Dogana P; Scarano MI; Caputo G; Cotrufo M; Santo LD; de Divitiis O
    Eur J Heart Fail; 2004 Jun; 6(4):389-98. PubMed ID: 15182762
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Determinants of high sensitivity troponin T concentration in chronic stable patients with heart failure: Ischemic heart failure versus non-ischemic dilated cardiomyopathy.
    Bakal RB; Hatipoglu S; Kahveci G; Omaygenc MO; Unkun T; Akgun T; Sahin M; Elveran A; Ozveren O; Ozdemir N
    Cardiol J; 2014; 21(1):67-75. PubMed ID: 23799554
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of muscle sympathetic activity in ischemic and nonischemic heart failure.
    Notarius CF; Spaak J; Morris BL; Floras JS
    J Card Fail; 2007 Aug; 13(6):470-5. PubMed ID: 17675061
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.